PFIZER INC
8-K, 1999-12-15
PHARMACEUTICAL PREPARATIONS
Previous: PFIZER INC, 8-K, 1999-12-15
 Next: POSSIS MEDICAL INC, 10-Q, 1999-12-15

 
Exhibit 99.1
   

A Message to Warner-Lambert Shareholders:

Superior Partner, Superior Offer

Yesterday
Pfizer has a far superior record of building value vs. American Home Products, with a total return this decade of 1297%
Total returns during the 1990s*
[BAR GRAPH]
1297%            382%
Pfizer            AHP
Today
Pfizer's offer represents a premium of 20% or $14 per share - $12 billion in additional value to you - compared to the AHP transaction**
20% Premium To The AHP Deal -
$14 Per Share
Tommorow
Pfizer/Warner-Lambert will be the strongest, fastest-growing pharmaceutical company in the world
  • $28 billion in combined revenues

  • $4 billion in annual R&D

  • Broad and deep product portfolio with at least 15 products over $500 million in sales
  • Strong presence in all major therapeutic and geographic markets

  • Projected annual EPS growth of 24%, 1999 to 2002

Your Board should give you the opportunity to take advantage of the offer that creates superior value, both now and in the future.

[PFIZER LOGO]

*Data from Bloomberg. Total returns from January 1, 1990 to December 13, 1999 with reinvestment of dividends

**Based on December 13 closing prices

 



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission